Literature DB >> 486695

The value of serum alkaline phosphatase alpha 1 isoenzyme in the diagnosis of liver metastases. Preliminary results.

M Viot, C Joulin, P Cambon, B P Krebs, M Schneider, C M Lalanne.   

Abstract

Serum alkaline phosphatase isoenzyme electrophoresis on cellulose acetate plates in a normal population of 91 controls and 255 cancer patients demonstrates the presence of an isoenzyme alpha 1 in 36 out of39 cases of confirmed liver metastases. In 188 cancer patients without apparent hepatic lesion and with a normal liver biology, the alpha 1 isoenzyme has been found in 45 cases, but 11 presented afterwards confirmed liver metastases. This isoenzyme remained negative in the normal population. Therefore, our results indicate that the alpha 1 alkaline phosphatase isoenzyme may be a useful marker for the biological diagnosis of liver metastases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486695

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  4 in total

1.  Measurement of biliary alkaline phosphatase by mini-column chromatography and by electrophoresis and its application to the detection of liver metastases in patients with breast cancer.

Authors:  C Karmen; P D Mayne; A Y Foo; S Parbhoo; S B Rosalki
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

2.  Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity.

Authors:  P D Mayne; S Thakrar; S B Rosalki; A Y Foo; S Parbhoo
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

3.  Reevaluation of alkaline phosphatase measurement during Hodgkin's disease by electrophoretic isoenzyme separation.

Authors:  A Thyss; M Schneider; C Caldani; M Viot; J Bourry
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

4.  Measurement of high molecular weight forms of enzymes in serum in the detection of hepatic metastases of colorectal cancer.

Authors:  O J Traynor; C B Wood; Z O Echetebu; K B Whitaker; D W Moss
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.